|Slideshows|December 5, 2017

13 Contributing Factors to Treatment-Resistant Bipolar Disorder

Author(s)Charles B. Schaffer, MD, Linda C. Schaffer, MD, Jeanne Howe, MA

Several non-biological factors often contribute significantly to treatment resistance.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Phase 2 Trial Initiated: LB-102 for Bipolar Depression

ByLeah Kuntz

January 26th 2026

sNDA Submission: Igalmi for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia in Outpatient Setting

ByLeah Kuntz

January 20th 2026

New Year’s Resolutions and Bipolar Disorder: Insights from Jo Hughes, DSMc, PA-C, CAQ-PSYCH

ByJo A. Hughes, DMSc, PA-C, CAQ-PSY,Jessica Walters

January 1st 2026

Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics

ByJessica Walters

December 24th 2025

An Update on the Role of Valproate in Bipolar Disorder

ByDavid N. Osser, MD

December 12th 2025

Latest CME

Video

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Michael Asbach, DMSc, PA-C; Erin Crown, MHS, PA-C, Psych-CAQ

Video

Optimizing Care for Patients With Tardive Dyskinesia

Amber Hoberg, MSN, APRN, PMHNP-BC; Erin Crown, PA-C, Psych-CAQ

Video

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Jonathan Meyer, MD; Jacob Hanaie, PharmD, APh, BCPP; Sanjai Rao, MD, DFAPA

13 Contributing Factors to Treatment-Resistant Bipolar Disorder

Newsletter

Related Content

Phase 2 Trial Initiated: LB-102 for Bipolar Depression

sNDA Submission: Igalmi for Acute Treatment of Agitation Associated With Bipolar Disorders or Schizophrenia in Outpatient Setting

New Year’s Resolutions and Bipolar Disorder: Insights from Jo Hughes, DSMc, PA-C, CAQ-PSYCH

Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics

An Update on the Role of Valproate in Bipolar Disorder

Latest CME

Managing Negative Symptoms of Schizophrenia: Can Prescription Digital Therapeutics Make an Impact?

Optimizing Care for Patients With Tardive Dyskinesia

Stabilize and Thrive: Prioritizing Patient Success Through Novel Therapeutic Management in Schizophrenia

Trending on Psychiatric Times

A New and Improved DSM? The American Psychiatric Association Shares Strategy and Roadmap

Addressing Co-Occurring ADHD and Autism, With Lauren Kenworthy, PhD

Updating the DSM: Reviewing the New APA DSM Recommendations

The Psychopharmacology of Personality Disorders

January 2026 in Review: Updates on the Psychiatric Treatment Pipeline